バイオエンジニアリングタンパク質医薬品の世界市場（～2026年）

• 英文タイトル：Global Bioengineered Proteins Drugs Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11064
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はバイオエンジニアリングタンパク質医薬品のグローバル市場について調査・分析したレポートです。種類別（サイトカイン・ケモカイン、モノクローナル抗体、治療用酵素、ペプチドホルモン、ペプチド抗生物質、ワクチン、その他）市場規模、用途別（糖尿病・ホルモン障害、遺伝・不妊障害、がん、臓器移植、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別バイオエンジニアリングタンパク質医薬品の競争状況、市場シェア
・世界のバイオエンジニアリングタンパク質医薬品市場：種類別市場規模 2015年-2020年（サイトカイン・ケモカイン、モノクローナル抗体、治療用酵素、ペプチドホルモン、ペプチド抗生物質、ワクチン、その他）
・世界のバイオエンジニアリングタンパク質医薬品市場：種類別市場規模予測 2021年-2026年（サイトカイン・ケモカイン、モノクローナル抗体、治療用酵素、ペプチドホルモン、ペプチド抗生物質、ワクチン、その他）
・世界のバイオエンジニアリングタンパク質医薬品市場：用途別市場規模 2015年-2020年（糖尿病・ホルモン障害、遺伝・不妊障害、がん、臓器移植、その他）
・世界のバイオエンジニアリングタンパク質医薬品市場：用途別市場規模予測 2021年-2026年（糖尿病・ホルモン障害、遺伝・不妊障害、がん、臓器移植、その他）
・北米のバイオエンジニアリングタンパク質医薬品市場分析：米国、カナダ
・ヨーロッパのバイオエンジニアリングタンパク質医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバイオエンジニアリングタンパク質医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバイオエンジニアリングタンパク質医薬品市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバイオエンジニアリングタンパク質医薬品市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Eli Lilly、F. Hoffmann-La Roche、Sanofi、Pfizer、GlaxoSmithKline、Novartis、Allergan、AbbVie、Agilent Technologies、Panacea Biotec、Wockhardt
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Bioengineered Proteins Drugs Market
The global Bioengineered Proteins Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bioengineered Proteins Drugs Scope and Market Size
Bioengineered Proteins Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bioengineered Proteins Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly
F. Hoffmann-La Roche
Sanofi
Pfizer
GlaxoSmithKline
Novartis
Allergan
AbbVie
Agilent Technologies
Panacea Biotec
Wockhardt

Market segment by Type, the product can be split into
Cytokines and Chemokines
Monoclonal Antibodies
Therapeutic Enzymes
Peptide Hormones
Peptide Antibiotics
Vaccines
Other
Market segment by Application, split into
Diabetes and Hormonal Disorders
Genetic and Fertility Disorders
Cancers
Organ Transplants
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bioengineered Proteins Drugs Revenue
1.4 Market by Type
1.4.1 Global Bioengineered Proteins Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cytokines and Chemokines
1.4.3 Monoclonal Antibodies
1.4.4 Therapeutic Enzymes
1.4.5 Peptide Hormones
1.4.6 Peptide Antibiotics
1.4.7 Vaccines
1.4.8 Other
1.5 Market by Application
1.5.1 Global Bioengineered Proteins Drugs Market Share by Application: 2020 VS 2026
1.5.2 Diabetes and Hormonal Disorders
1.5.3 Genetic and Fertility Disorders
1.5.4 Cancers
1.5.5 Organ Transplants
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bioengineered Proteins Drugs Market Perspective (2015-2026)
2.2 Global Bioengineered Proteins Drugs Growth Trends by Regions
2.2.1 Bioengineered Proteins Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bioengineered Proteins Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Bioengineered Proteins Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bioengineered Proteins Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Bioengineered Proteins Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bioengineered Proteins Drugs Players by Market Size
3.1.1 Global Top Bioengineered Proteins Drugs Players by Revenue (2015-2020)
3.1.2 Global Bioengineered Proteins Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Bioengineered Proteins Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bioengineered Proteins Drugs Market Concentration Ratio
3.2.1 Global Bioengineered Proteins Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bioengineered Proteins Drugs Revenue in 2019
3.3 Bioengineered Proteins Drugs Key Players Head office and Area Served
3.4 Key Players Bioengineered Proteins Drugs Product Solution and Service
3.5 Date of Enter into Bioengineered Proteins Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bioengineered Proteins Drugs Historic Market Size by Type (2015-2020)
4.2 Global Bioengineered Proteins Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bioengineered Proteins Drugs Market Size by Application (2015-2020)
5.2 Global Bioengineered Proteins Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bioengineered Proteins Drugs Market Size (2015-2020)
6.2 Bioengineered Proteins Drugs Key Players in North America (2019-2020)
6.3 North America Bioengineered Proteins Drugs Market Size by Type (2015-2020)
6.4 North America Bioengineered Proteins Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bioengineered Proteins Drugs Market Size (2015-2020)
7.2 Bioengineered Proteins Drugs Key Players in Europe (2019-2020)
7.3 Europe Bioengineered Proteins Drugs Market Size by Type (2015-2020)
7.4 Europe Bioengineered Proteins Drugs Market Size by Application (2015-2020)

8 China
8.1 China Bioengineered Proteins Drugs Market Size (2015-2020)
8.2 Bioengineered Proteins Drugs Key Players in China (2019-2020)
8.3 China Bioengineered Proteins Drugs Market Size by Type (2015-2020)
8.4 China Bioengineered Proteins Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bioengineered Proteins Drugs Market Size (2015-2020)
9.2 Bioengineered Proteins Drugs Key Players in Japan (2019-2020)
9.3 Japan Bioengineered Proteins Drugs Market Size by Type (2015-2020)
9.4 Japan Bioengineered Proteins Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bioengineered Proteins Drugs Market Size (2015-2020)
10.2 Bioengineered Proteins Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bioengineered Proteins Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Bioengineered Proteins Drugs Market Size by Application (2015-2020)

11 India
11.1 India Bioengineered Proteins Drugs Market Size (2015-2020)
11.2 Bioengineered Proteins Drugs Key Players in India (2019-2020)
11.3 India Bioengineered Proteins Drugs Market Size by Type (2015-2020)
11.4 India Bioengineered Proteins Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bioengineered Proteins Drugs Market Size (2015-2020)
12.2 Bioengineered Proteins Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Bioengineered Proteins Drugs Market Size by Type (2015-2020)
12.4 Central & South America Bioengineered Proteins Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Bioengineered Proteins Drugs Introduction
13.1.4 Eli Lilly Revenue in Bioengineered Proteins Drugs Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Bioengineered Proteins Drugs Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Bioengineered Proteins Drugs Introduction
13.3.4 Sanofi Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Bioengineered Proteins Drugs Introduction
13.4.4 Pfizer Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Bioengineered Proteins Drugs Introduction
13.5.4 GlaxoSmithKline Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Bioengineered Proteins Drugs Introduction
13.6.4 Novartis Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Allergan
13.7.1 Allergan Company Details
13.7.2 Allergan Business Overview
13.7.3 Allergan Bioengineered Proteins Drugs Introduction
13.7.4 Allergan Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.7.5 Allergan Recent Development
13.8 AbbVie
13.8.1 AbbVie Company Details
13.8.2 AbbVie Business Overview
13.8.3 AbbVie Bioengineered Proteins Drugs Introduction
13.8.4 AbbVie Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.8.5 AbbVie Recent Development
13.9 Agilent Technologies
13.9.1 Agilent Technologies Company Details
13.9.2 Agilent Technologies Business Overview
13.9.3 Agilent Technologies Bioengineered Proteins Drugs Introduction
13.9.4 Agilent Technologies Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.9.5 Agilent Technologies Recent Development
13.10 Panacea Biotec
13.10.1 Panacea Biotec Company Details
13.10.2 Panacea Biotec Business Overview
13.10.3 Panacea Biotec Bioengineered Proteins Drugs Introduction
13.10.4 Panacea Biotec Revenue in Bioengineered Proteins Drugs Business (2015-2020)
13.10.5 Panacea Biotec Recent Development
13.11 Wockhardt
10.11.1 Wockhardt Company Details
10.11.2 Wockhardt Business Overview
10.11.3 Wockhardt Bioengineered Proteins Drugs Introduction
10.11.4 Wockhardt Revenue in Bioengineered Proteins Drugs Business (2015-2020)
10.11.5 Wockhardt Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Bioengineered Proteins Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Bioengineered Proteins Drugs Revenue
Table 3. Ranking of Global Top Bioengineered Proteins Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bioengineered Proteins Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cytokines and Chemokines
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Therapeutic Enzymes
Table 8. Key Players of Peptide Hormones
Table 9. Key Players of Peptide Antibiotics
Table 10. Key Players of Vaccines
Table 11. Key Players of Other
Table 12. Global Bioengineered Proteins Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Bioengineered Proteins Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Bioengineered Proteins Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Bioengineered Proteins Drugs Market Share by Regions (2015-2020)
Table 16. Global Bioengineered Proteins Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Bioengineered Proteins Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Bioengineered Proteins Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Bioengineered Proteins Drugs Players
Table 23. Global Bioengineered Proteins Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Bioengineered Proteins Drugs Market Share by Players (2015-2020)
Table 25. Global Top Bioengineered Proteins Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioengineered Proteins Drugs as of 2019)
Table 26. Global Bioengineered Proteins Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Bioengineered Proteins Drugs Product Solution and Service
Table 29. Date of Enter into Bioengineered Proteins Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Bioengineered Proteins Drugs Market Size Share by Type (2015-2020)
Table 33. Global Bioengineered Proteins Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Bioengineered Proteins Drugs Market Size Share by Application (2015-2020)
Table 35. Global Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Bioengineered Proteins Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 39. North America Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 41. North America Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 45. Europe Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 47. Europe Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 51. China Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 53. China Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 57. Japan Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 59. Japan Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 63. Southeast Asia Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 69. India Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 71. India Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Bioengineered Proteins Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Bioengineered Proteins Drugs Market Share (2019-2020)
Table 75. Central & South America Bioengineered Proteins Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Bioengineered Proteins Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Bioengineered Proteins Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Bioengineered Proteins Drugs Market Share by Application (2015-2020)
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Product
Table 82. Eli Lilly Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 83. Eli Lilly Recent Development
Table 84. F. Hoffmann-La Roche Company Details
Table 85. F. Hoffmann-La Roche Business Overview
Table 86. F. Hoffmann-La Roche Product
Table 87. F. Hoffmann-La Roche Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Allergan Company Details
Table 110. Allergan Business Overview
Table 111. Allergan Product
Table 112. Allergan Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 113. Allergan Recent Development
Table 114. AbbVie Business Overview
Table 115. AbbVie Product
Table 116. AbbVie Company Details
Table 117. AbbVie Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 118. AbbVie Recent Development
Table 119. Agilent Technologies Company Details
Table 120. Agilent Technologies Business Overview
Table 121. Agilent Technologies Product
Table 122. Agilent Technologies Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 123. Agilent Technologies Recent Development
Table 124. Panacea Biotec Company Details
Table 125. Panacea Biotec Business Overview
Table 126. Panacea Biotec Product
Table 127. Panacea Biotec Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 128. Panacea Biotec Recent Development
Table 129. Wockhardt Company Details
Table 130. Wockhardt Business Overview
Table 131. Wockhardt Product
Table 132. Wockhardt Revenue in Bioengineered Proteins Drugs Business (2015-2020) (Million US$)
Table 133. Wockhardt Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioengineered Proteins Drugs Market Share by Type: 2020 VS 2026
Figure 2. Cytokines and Chemokines Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Therapeutic Enzymes Features
Figure 5. Peptide Hormones Features
Figure 6. Peptide Antibiotics Features
Figure 7. Vaccines Features
Figure 8. Other Features
Figure 9. Global Bioengineered Proteins Drugs Market Share by Application: 2020 VS 2026
Figure 10. Diabetes and Hormonal Disorders Case Studies
Figure 11. Genetic and Fertility Disorders Case Studies
Figure 12. Cancers Case Studies
Figure 13. Organ Transplants Case Studies
Figure 14. Others Case Studies
Figure 15. Bioengineered Proteins Drugs Report Years Considered
Figure 16. Global Bioengineered Proteins Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Bioengineered Proteins Drugs Market Share by Regions: 2020 VS 2026
Figure 18. Global Bioengineered Proteins Drugs Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Bioengineered Proteins Drugs Market Share by Players in 2019
Figure 21. Global Top Bioengineered Proteins Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioengineered Proteins Drugs as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Bioengineered Proteins Drugs Revenue in 2019
Figure 23. North America Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Bioengineered Proteins Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed

以下、関連資料のご紹介

遺伝子組み換え食品の世界市場（～2026年）

Global Bioengineered Food Market Insights and Forecast to 2026
MRC2-11QY03219 2020年11月20日 117Pages
当調査資料は遺伝子組み換え食品のグローバル市場について調査・分析したレポートです。種類別（畜産物、作物、果物、野菜）市場規模、用途別（農業、実験）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中...

治療用組換え抗体・タンパク質の世界市場（～2026年）

Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2020-2026
MRC2-11QY04472 2020年11月20日 91Pages
当調査資料は治療用組換え抗体・タンパク質のグローバル市場について調査・分析したレポートです。種類別（血漿たんぱく質、融合たんぱく質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）市場規模、用途別（腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他）市場規模、地域別（北米、米国、カナ...

DNA修復タンパク質・試薬の世界市場（～2026年）

Global DNA Repair Proteins And Reagents Market Size, Status and Forecast 2020-2026
MRC2-11QY11699 2020年11月25日 90Pages
当調査資料はDNA修復タンパク質・試薬のグローバル市場について調査・分析したレポートです。種類別（アッセイキット、試薬、消耗品）市場規模、用途別（バイオテクノロジー・製薬会社、研究機関、法医学研究所、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

骨形成タンパク質の世界市場（～2026年）

Global Bone Morphogenetic Proteins Market Insights and Forecast to 2026
MRC2-11QY03394 2020年11月20日 112Pages
当調査資料は骨形成タンパク質のグローバル市場について調査・分析したレポートです。種類別（rhBMP-2、rhBMP-7）市場規模、用途別（脊椎固定術、外傷、再建手術、口腔顎顔面）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

経口タンパク質・ペプチドの世界市場（～2026年）

Global Oral Proteins and Peptides Market Insights and Forecast to 2026
MRC2-11QY08406 2020年11月20日 118Pages
当調査資料は経口タンパク質・ペプチドのグローバル市場について調査・分析したレポートです。種類別（リナクロチド、カルシトニン、インスリン、オクトレオチド）市場規模、用途別（胃・消化器疾患、骨疾患、糖尿病、ホルモン性疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

レクティス（炭水化物結合タンパク質）の世界市場（～2026年）

Global Lectis(Carbohydrate Binding Proteins) Market Insights and Forecast to 2026
MRC2-11QY07147 2020年11月20日 151Pages
当調査資料はレクティス（炭水化物結合タンパク質）のグローバル市場について調査・分析したレポートです。種類別（純度90％以下、純度90％-95％、純度95％-99％、純度99％以上）市場規模、用途別（バイオ製薬会社、病院、生物科学研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイ...

泌尿生殖器治療薬の世界市場（～2026年）

Global Genitourinary Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY12028 2020年11月25日 98Pages
当調査資料は泌尿生殖器治療薬のグローバル市場について調査・分析したレポートです。種類別（泌尿器科、ホルモン療法、婦人科、抗感染薬）市場規模、用途別（前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁・過活動膀胱、性感染症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ...

発酵タンパク質の世界市場（～2026年）

Global Fermented Proteins Market Insights and Forecast to 2026
MRC2-11QY06049 2020年11月20日 119Pages
当調査資料は発酵タンパク質のグローバル市場について調査・分析したレポートです。種類別（GMOフリー、グルテンフリー、GMO）市場規模、用途別（人間用消耗品、動物用消耗品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

組換えヒトタンパク質の世界市場（～2026年）

Global Recombinant Human Proteins Market Insights and Forecast to 2026
MRC2-11QY08972 2020年11月25日 118Pages
当調査資料は組換えヒトタンパク質のグローバル市場について調査・分析したレポートです。種類別（たんぱく質生産、たんぱく質精製）市場規模、用途別（研究所、医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

鼻血治療薬の世界市場（～2026年）

Global Epistaxis Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY11878 2020年11月25日 99Pages
当調査資料は鼻血治療薬のグローバル市場について調査・分析したレポートです。種類別（血管収縮剤、麻酔薬、抗生物質軟膏、焼灼剤、その他）市場規模、用途別（病院、クリニック、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
遺伝子組み換え食品の世界市場（～2026年） The bioengineered food is genetically modified food which is produced from organisms. The global bioengineered food market growth is driven by following factors: increasing demand for nutritional and healthy food, decreases requirement of pesticides, rising yield production along with the increasing…
無菌注射薬の世界市場（～2026年） Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalenc…
DNA修復タンパク質・試薬の世界市場（～2026年） Everyday exposure to ecological microorganisms (receptive oxygen species, methylating operators, UV light, and other radiation) exposure to natural specialists and typical physiological procedures (replication and recombination) all harm DNA. Cells must repair the damaged DNA to prevent it from furt…
眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…